The purpose of this study is to compare the usual treatment alone (FOLFOX or CAPOX after chemoradiation) to using FOLFIRINOX after chemoradiation.
Learn more about the A022104/JANUS trial or call the Reading Hospital Cancer Research Office at 484-628-8193.
